Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dragan Sebisanovic

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Research|January 20, 2007
Distinguishing cancer-associated missense mutations from common polymorphismsJoshua S Kaminker, Yan Zhang, Allison Waugh, et al.
Plos One|October 17, 2015
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNARichard B Lanman, Stefanie A Mortimer, Oliver A Zill, et al.
Nature Methods|August 21, 2007
Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detectionBrock A Peters, Zhengyan Kan, Dragan Sebisanovic, et al.
Cancer Discovery|June 26, 2015
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary CarcinomasOliver A Zill, Claire Greene, Dragan Sebisanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2005
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinibDavid A Eberhard, Bruce E Johnson, Lukas C Amler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Research|January 20, 2007
Distinguishing cancer-associated missense mutations from common polymorphismsJoshua S Kaminker, Yan Zhang, Allison Waugh, et al.
Plos One|October 17, 2015
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNARichard B Lanman, Stefanie A Mortimer, Oliver A Zill, et al.
Nature Methods|August 21, 2007
Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detectionBrock A Peters, Zhengyan Kan, Dragan Sebisanovic, et al.
Cancer Discovery|June 26, 2015
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary CarcinomasOliver A Zill, Claire Greene, Dragan Sebisanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2005
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinibDavid A Eberhard, Bruce E Johnson, Lukas C Amler, et al.
Pageof 1